MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1

Publisher： Karger

E-ISSN： 1421-9778|35|5|1846-1856

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.35, Iss.5, 2015-03, pp. : 1846-1856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma

By  

Cellular Physiology and Biochemistry, Vol. 37, Iss. 5, 2015-0 ,pp. : 1956-1966

Karger

Access to resources Recommend Favorite

MiR-940 Inhibited Pancreatic Ductal Adenocarcinoma Growth by Targeting MyD88

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 3, 2015-02 ,pp. : 1167-1177

Karger

Access to resources Recommend Favorite

Modulation of FoxO1 Expression by miR-21 to Promote Growth of Pancreatic Ductal Adenocarcinoma

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 1, 2015-01 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt

By  

Cellular Physiology and Biochemistry, Vol. 38, Iss. 6, 2016-05 ,pp. : 2366-2374

Karger

Access to resources Recommend Favorite

miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1

By  

Cellular Physiology and Biochemistry, Vol. 32, Iss. 6, 2013-12 ,pp. : 1808-1817

Karger

Access to resources Recommend Favorite